Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib

Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012

iwNHL 10: Advances in the treatment of lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal
iwNHL 10: Advances in the treatment of lymphoma ( Dr Wyndham Wilson -  National Cancer Institute, Bethesda, MD, USA;  Dr Myron Czuczman -  Roswell Park Cancer Institute, Buffalo, NY, USA;  Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal )
26 Sep 2012

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012

Highlights from the 2012 NCID Meeting

Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Highlights from the 2012 NCID Meeting ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
23 Jul 2012

International Network of bio-banks and expert centres

Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz, Austria
International Network of bio-banks and expert centres ( Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz, Austria )
23 Jul 2012

The impact of breast cancer in Africa

Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria
The impact of breast cancer in Africa ( Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria )
20 Jul 2012

Landscape of cancer care in Bangladesh

Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh
Landscape of cancer care in Bangladesh ( Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh )
20 Jul 2012

Circulating metastasis-initiating cells in breast cancer

Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
Circulating metastasis-initiating cells in breast cancer ( Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany )
19 Jul 2012

The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )
19 Jul 2012

Understanding the mechanisms of breast cancer resistance

Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
Understanding the mechanisms of breast cancer resistance ( Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jul 2012

Translational and tailored, but can we afford it?

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012